Drug intelligence / Profile preview

naoshuantong

Development stage
Phase 4
Lead developer
Buchang Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Naoshuantong is a Traditional Chinese Medicine (TCM) formulation primarily used in China for the treatment of ischemic stroke and other cerebrovascular diseases. It is a multi-component mixture typically containing extracts from *Hirudo* (leech), *Radix Astragali*, *Radix Salviae Miltiorrhizae*, *Radix et Rhizoma Notoginseng*, and *Rhizoma Chuanxiong*. The therapeutic mechanism is attributed to its ability to inhibit thrombin activity (via hirudin from the leech component), suppress platelet aggregation, improve microcirculation, and provide neuroprotection against ischemic injury. It is widely marketed in China and is currently being evaluated in clinical trials to further establish its efficacy in reducing stroke recurrence in high-risk populations.

Brand names
Naoshuantong Capsule
Other names
Naoshuantong Jiaonang
02

Targets

ALB (Human serum albumin)CASP3 (Caspase-3)TP53 (Cellular Tumor Antigen p53 R175H)VEGFA (Vascular endothelial growth factor A)F2 (Thrombin)

Beyond the preview

Go deeper on naoshuantong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naoshuantong.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call